Analysis of US Food and Drug Administration Warning Letters: False Promotional Claims Relating to Prescription and Over-the-Counter Medications

Author： Salas Maribel  

Publisher： Adis International

ISSN： 1178-2595

Source： Pharmaceutical Medicine, Vol.22, Iss.2, 2008-01, pp. : 119-125

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Retracted: Prescription to over-the-counter movement and its regulations

By Dubey S. K.  

Clinical Research and Regulatory Affairs, Vol. 29, Iss. 3-4, 2012-12 ,pp. : 57-64

Informa Healthcare

Access to resources Recommend Favorite

The Effect of Generic Competition on Prescription to Over-the-Counter Switching

By Hollenbeak C.S.  

PharmacoEconomics, Vol. 16, Iss. 6, 1999-12 ,pp. : 661-668

Adis International

Access to resources Recommend Favorite

The US Food and Drug Administration and Emergency Contraception

By Fox Anthony W.  

International Journal of Pharmaceutical Medicine, Vol. 19, Iss. 3, 2005-01 ,pp. : 139-140

Adis International

Access to resources Recommend Favorite

Global over-the-counter (OTC) drug sales for Novartis rose 5% in 2001

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 350, 2002-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Clinical Significance of Pharmacokinetic Drug Interactions with Over-the-Counter (OTC) Drugs

By Honig P.K.  

Clinical Pharmacokinetics, Vol. 35, Iss. 3, 1998-09 ,pp. : 167-171

Adis International

Access to resources Recommend Favorite